Skip to main content
. 2021 Aug;103:159–170. doi: 10.1016/j.reprotox.2021.06.006

Fig. 1.

Fig. 1

Simplified mechanistic knowledge captured in AOPs speeds up development of relevant in vitro DNT assays to be further incorporated in the existing DNT-IVB and insures coverage of key DNT mechanisms. Schematic representation of impaired key neurodevelopmental processes defined as key events (KEs) in DNT AOPs (hiPSCs: human induced pluripotent stem cells; NPCs: Neural Precursor cells; MIE: Molecular Initiating Event; AO: Adverse Outcome).